Author

Emily Cahill

Observed name: E.A. Cahill

Institution: American Society of Hematology

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, American Society of Hematology

ORCID: 0000-0003-2654-6370

Observed ORCID: 0000-0003-2654-6370

OpenAlex ID: A5038601248

Systems-based hematology: highlighting successes and next steps

2020 · Jori E. May, Patrick C. Irelan, et al. · Blood Advances · 16

An oral caspase inhibitor as monotherapy or with antibiotics eradicates MRSA skin infections in mice

2023 · Emily Cahill, Olusola O. Oladipo, et al. · Drug Development Research · 5

Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis

2025 · Lisa Baumann Kreuziger, Megan Keenan, et al. · American Journal of Medical Quality · 2

Evaluation of the American society of hematology quality improvement training institute: Impact on learner quality improvement knowledge, confidence, and satisfaction

2025 · Michael Keng, Menaka Pai, et al. · Blood · 1

Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department

2025 · Damon E Houghton, Megan Keenan, et al. · Vascular Medicine · 1

Results from Multisite Implementation of Electronic Health Record Tools for Clinical Pre-Test Probability of Pulmonary Embolism in the Emergency Department

2023 · Damon E. Houghton, Lisa Baumann Kreuziger, et al. · Blood · 1

Survey of Pulmonary Embolism Risk Stratification Methods in the Emergency Department and Barriers to Electronic Health Record Documentation

2023 · Rachel P. Rosovsky, Damon E. Houghton, et al. · Blood · 1

MedEdPORTAL: A Report on Oral Health Resources for Health Professions Educators

2013 · Nithya S. Chickmagalur, Veerasathpurush Allareddy, et al. · Journal of Dental Education · 1

Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis

2023 · Lisa Baumann Kreuziger, Megan Keenan, et al. · Blood

ISID1008 - The irreversible pan-caspase inhibitor emricasan is a potential host-directed immunotherapy against methicillin-resistant S. aureus (MRSA) skin infections in mice

2023 · Emily Cahill

1008 The irreversible pan-caspase inhibitor emricasan is a potential host-directed immunotherapy against methicillin-resistant S. aureus (MRSA) skin infections in mice

2023 · E.A. Cahill, O.O. Oladipo, et al. · Journal of Investigative Dermatology

Works count: 11

Citation count: 28

H-index: 2

I10-index: 1